Afatinib increases progression-free survival in subset of patients w lung cancer. @pwendl reports. http://bit.ly/e3fNEu
1:12 PM - 13 Dec 2010
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.